| | Title | Authors / Editors | Date |
|
unige:7704 |
Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infection |
Yerly Ferrillo, Sabine; Perneger, T. V.; Vora, S.; Hirschel, Bernard; Perrin, Luc |
2000 |
|
unige:7107 |
HIV transmission after suspension of highly active antiretroviral therapy |
Bernasconi, Enos; Vernazza, P. L.; Bernasconi, Alessandra; Hirschel, Bernard |
2001 |
|
unige:7282 |
Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy |
Greub, Gilbert; Cozzi-Lepri, Alessandro; Ledergerber, Bruno; Staszewski, Schlomo; ... Telenti, Amalio |
2002 |
|
unige:7358 |
A patient with HIV-1 superinfection |
Jost, Stéphanie; Bernard, Marie-Charlotte; Kaiser, Laurent; Yerly Ferrillo, Sabine; ... Perrin, Luc |
2002 |
|
unige:7434 |
Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA study |
Mocroft, A.; Phillips, A. N.; Friis-Moller, N.; Colebunders, R.; ... Lundgren, J. D. |
2002 |
|
unige:7454 |
Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 x 10(6) |
Opravil, Milos; Ledergerber, Bruno; Furrer, Hansjakob; Hirschel, Bernard; ... Weber, Rainer |
2002 |
|
unige:7458 |
Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection |
Oxenius, Annette; Price, D. A.; Gunthard, Huldrych; Dawson, S. J.; ... Phillips, R. E. |
2002 |
|
unige:7151 |
Weight-losing HIV-infected patients on recombinant human growth hormone for 12 wk: a national study |
Cominelli, Silvano; Raguso, C. A.; Karsegard, Laurie; Hirschel, Bernard; ... Pichard, Claude |
2002 |
|
unige:7157 |
Supervised interruptions of antiretroviral therapy |
Deeks, S. G.; Hirschel, Bernard |
2002 |
|
unige:7598 |
Impact of occasional short interruptions of HAART on the progression of HIV infection: results from a cohort study |
Taffe, Patrick; Rickenbach, Martin; Hirschel, Bernard; Opravil, Milos; ... Sudre, Philippe |
2002 |
|
unige:9349 |
Is autovaccination dead? |
Hirschel, Bernard |
2003 |
|
unige:9410 |
Structured treatment interruptions in HIV infection: benefit or disappointment? |
Oxenius, Annette; Hirschel, Bernard |
2003 |
|
unige:7353 |
Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population |
Jaggy, Christian; von Overbeck, Jan; Ledergerber, Bruno; Schwarz, Claude; ... Hirschel, Bernard |
2003 |
|
unige:7373 |
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study |
Kaufmann, G. R.; Perrin, Luc; Pantaleo, Guiseppe; Opravil, Milos; ... Battegay, Manuel |
2003 |
|
unige:7195 |
A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART |
Fagard, Catherine; Le Braz, Michelle; Gunthard, Huldrych; Hirsch, H. H.; ... Hirschel, Bernard |
2003 |
|
unige:7196 |
A prospective trial of structured treatment interruptions in human immunodeficiency virus infection |
Fagard, Catherine; Oxenius, Annette; Gunthard, Huldrych; Garcia, Felipe; ... Hirschel, Bernard |
2003 |
|
unige:7697 |
Drug resistance mutations during structured treatment interruptions |
Yerly Ferrillo, Sabine; Fagard, Catherine; Gunthard, Huldrych; Hirschel, Bernard; Perrin, Luc |
2003 |
|
unige:7089 |
Pharmacokinetic study of saquinavir hard gel caps/ritonavir in HIV-1-infected patients: 1600/100 mg once-daily compared with 2000/100 mg once-daily and 1000/100 mg twice-daily |
Autar, R. S.; Ananworanich, J.; Apateerapong, W.; Sankote, J.; ... Burger, Danielle |
2004 |
|
unige:7372 |
Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection |
Kaufmann, G. R.; Khanna, Nina; Weber, Rainer; Perrin, Luc; ... Battegay, Manuel |
2004 |
|
unige:7214 |
Attenuated and nonproductive viral transcription in the lymphatic tissue of HIV-1-infected patients receiving potent antiretroviral therapy |
Fischer, Marek; Joos, Beda; Wong, J. K.; Ott, Peter; ... Gunthard, Huldrych |
2004 |
|
unige:7698 |
Proviral HIV-DNA predicts viral rebound and viral setpoint after structured treatment interruptions |
Yerly Ferrillo, Sabine; Gunthard, Huldrych; Fagard, Catherine; Joos, Beda; ... Perrin, Luc |
2004 |
|
unige:7135 |
A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection |
Cardiello, Peter; Hassink, Elly; Ananworanich, Jintanat; Srasuebkul, Preeyaporn; ... Cooper, David |
2005 |
|
unige:7713 |
Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study |
Young, Jim; Weber, Rainer; Rickenbach, Martin; Furrer, Hansjakob; ... Bucher, H. C. |
2005 |
|
unige:7581 |
HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell loss |
Schupbach, Jorg; Gunthard, Huldrych; Joos, Beda; Fischer, Marek; ... Hirschel, Bernard |
2005 |
|
unige:47163 |
The clinical characteristics of HIV-infected patients receiving dialysis in France between 1997 and 2002 |
Vigneau, Cecile; Guiard-Schmid, Jean-Baptiste; Tourret, Jerome; Flahault, Antoine; ... Rondeau, Eric |
2005 |
|
unige:7081 |
Absence of resistance mutations in antiretroviral-naive patients treated with ritonavir-boosted saquinavir |
Ananworanich, Jintanat; Hirschel, Bernard; Sirivichayakul, Sunee; Ubolyam, Sasiwimol; ... Ruxrungtham, Kiat |
2006 |
|
unige:7276 |
Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study |
Glass, T. R.; De Geest, Sabina; Weber, Rainer; Vernazza, P. L.; ... Bucher, H. C. |
2006 |
|
unige:7277 |
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study |
Glass, T. R.; Ungsedhapand, C.; Wolbers, M.; Weber, R.; ... Bucher, H. C. |
2006 |
|
unige:7094 |
Late presentation of HIV-infected individuals |
Battegay, Manuel; Fluckiger, Ursula; Hirschel, Bernard; Furrer, Hansjakob |
2007 |
|
unige:7244 |
Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study |
Fux, C. A.; Simcock, Mathew; Wolbers, Marcel; Bucher, H. C.; ... Furrer, Hansjakob |
2007 |
|
unige:7262 |
No change in calculated creatinine clearance after tenofovir initiation among Thai patients |
Gayet-Ageron, Angèle; Ananworanich, Jintanat; Jupimai, Thidarat; Chetchotisakd, Ploenchan; ... Hirschel, Bernard |
2007 |
|
unige:7278 |
Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study |
Glass, T. R.; Weber, Rainer; Vernazza, P. L.; Rickenbach, Martin; ... Bucher, H. C. |
2007 |
|
unige:7374 |
Adverse events to antiretrovirals in the Swiss HIV Cohort Study: effect on mortality and treatment modification |
Keiser, Olivia; Fellay, Jacques; Opravil, Milos; Hirsch, H. H.; ... Furrer, Hansjakob |
2007 |
|
unige:7402 |
Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study |
Ledergerber, Bruno; Furrer, Hansjakob; Rickenbach, Martin; Lehmann, Roger; ... Weber, Rainer |
2007 |
|
unige:7677 |
Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types |
von Wyl, Viktor; Yerly Ferrillo, Sabine; Boni, Jurg; Burgisser, Philippe; ... Gunthard, Huldrych |
2007 |
|
unige:7690 |
CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy |
Wolbers, Marcel; Battegay, Manuel; Hirschel, Bernard; Furrer, Hansjakob; ... Bucher, H. C. |
2007 |
|
unige:7691 |
Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study |
Wolbers, Marcel; Opravil, Milos; von Wyl, Viktor; Hirschel, Bernard; ... Bucher, H. C. |
2007 |
|
unige:7583 |
Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study |
Simcock, Mathew; Blasko, Monika; Karrer, Urs; Bertisch, Barbara; ... Koller, M. T. |
2007 |
|
unige:7078 |
Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir |
Ananworanich, Jintanat; Gayet-Ageron, Angèle; Ruxrungtham, Kiat; Chetchotisakd, Ploenchan; ... Hirschel, Bernard |
2008 |
|
unige:1715 |
Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy |
Polesel, Jerry; Clifford, Gary M.; Rickenbach, Martin; Dal Maso, Luigino; ... Franceschi, Silvia |
2008 |
|
unige:1781 |
HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy |
Oehler-Jänne, Christoph; Huguet, Florence; Provencher, Sawyna; Seifert, Burkhardt; ... Ciernik, I Frank |
2008 |
|
unige:1868 |
Brueghel syndrome as a new manifestation of HIV encephalopathy |
Wicki, Jacques; Germanier, Yves; Sztajzel, Roman; Burkhard, Pierre |
2008 |
|
unige:7447 |
Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection |
Nuesch, Reto; Ananworanich, Jintanat; Srasuebkul, Preeyaporn; Chetchotisakd, Ploenchan; ... Hirschel, Bernard |
2008 |
|
unige:7671 |
HIV transmission under highly active antiretroviral therapy |
Vernazza, Pietro; Hirschel, Bernard; Bernasconi, Enos; Flepp, Markus |
2008 |
|
unige:2091 |
The Monark trial: where now for boosted protease inhibitor monotherapy? |
Hill, Andrew; Hirschel, Bernard; Katlama, Christine |
2008 |
|
unige:2092 |
Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir |
von Wyl, Viktor; Yerly Ferrillo, Sabine; Böni, Jürg; Bürgisser, Philippe; ... Günthard, Huldrych F. |
2008 |
|
unige:2096 |
HLA-Bw4 homozygosity is associated with an impaired CD4 T cell recovery after initiation of antiretroviral therapy |
Rauch, Andri; Nolan, David; Furrer, Hansjakob; McKinnon, Elizabeth; ... James, Ian |
2008 |
|
unige:2098 |
Androgen and gonadotropin patterns differ in HIV-1-infected men who develop lipoatrophy during antiretroviral therapy: a case-control study |
Wunder, D M.; Fux, C A.; Bersinger, N A.; Mueller, N J.; ... Furrer, H. |
2008 |
|
unige:2100 |
Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy |
Franceschi, S.; Dal Maso, L.; Rickenbach, M.; Polesel, J.; ... Clifford, G M. |
2008 |
|
unige:1128 |
Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era |
Boffi El Amari, Emmanuelle Jane; Toutous Trellu, Laurence Marie; Gayet-Ageron, Angèle; Baumann, Michele; ... Hirschel, Bernard |
2008 |
Antiretroviral therapy, highly active
add all
remove all
